| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M103984200 |
| P698 | PubMed publication ID | 11495902 |
| P2093 | author name string | Muffat-Joly M | |
| Walker F | |||
| Bichara M | |||
| Isnard R | |||
| Le Menuet D | |||
| Lombès M | |||
| Viengchareun S | |||
| Zennaro MC | |||
| P2860 | cites work | Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor | Q22254872 |
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism | Q28506467 | ||
| The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action | Q28581682 | ||
| A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization | Q29618351 | ||
| Epithelial sodium channel regulated by aldosterone-induced protein sgk. | Q30650629 | ||
| Pleiotropic action of aldosterone in epithelia mediated by transcription and post-transcription mechanisms | Q33888847 | ||
| Brain mineralocorticoid receptors and centrally regulated functions. | Q33888882 | ||
| Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice | Q35029130 | ||
| Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. | Q37379344 | ||
| Modulation of human mineralocorticoid receptor function by protein kinase A. | Q38329262 | ||
| Mineralocorticoids, hypertension, and cardiac fibrosis | Q40337147 | ||
| Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms | Q42528029 | ||
| Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice | Q43583255 | ||
| High-affinity aldosterone binding in rat liver--a re-evaluation | Q44295872 | ||
| High affinity aldosterone binding sites (type I receptors) in the mammalian inner ear. | Q46327093 | ||
| sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels | Q47958475 | ||
| Human mineralocorticoid receptor genomic structure and identification of expressed isoforms | Q48070725 | ||
| Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice. | Q52533848 | ||
| Syndromes of glucocorticoid and mineralocorticoid resistance. | Q54126348 | ||
| Rescue of the mineralocorticoid receptor knock-out mouse | Q59278413 | ||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 38911-38920 | |
| P577 | publication date | 2001-08-08 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor | |
| P478 | volume | 276 |
| Q37763640 | Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome |
| Q44648728 | Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction |
| Q28580332 | Aldosterone modulates I(f) current through gene expression in cultured neonatal rat ventricular myocytes |
| Q46976034 | Aldosterone, ion channels, and sudden death: another piece of the circle? |
| Q28570951 | Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy |
| Q35046503 | Aldosterone: a risk factor for vascular disease |
| Q35173847 | Aldosterone: its receptor, target genes, and actions |
| Q46240581 | Association of SGK 1 Gene polymorphisms with type 2 diabetes |
| Q39579480 | Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction |
| Q37366263 | Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis |
| Q35805020 | CRH, stress, and major depression: a psychobiological interplay. |
| Q45231099 | Comparison of the effects of intrapericardial and intravenous aldosterone infusions on left ventricular fibrosis in rats |
| Q36793743 | Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias |
| Q35173851 | Corticosteroid receptors, 11 beta-hydroxysteroid dehydrogenase, and the heart |
| Q33856656 | Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation. |
| Q35839992 | Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice |
| Q36232568 | Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice |
| Q33340170 | Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies |
| Q34759691 | Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin. |
| Q39674733 | Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex |
| Q35447336 | Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates |
| Q51464359 | Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats. |
| Q37517178 | Mineralocorticoid receptor activation in obesity hypertension |
| Q36804573 | Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons |
| Q39726044 | Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency. |
| Q39912709 | Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease |
| Q34065505 | Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line. |
| Q54614555 | Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice. |
| Q38925399 | Photoperiodicity and increasing salinity as environmental cues for reproduction in desert adapted rodents |
| Q46983870 | Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury |
| Q28191206 | Pseudohyperaldosteronism: pathogenetic mechanisms |
| Q38839225 | Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms |
| Q35023717 | Regulation of mineralocorticoid receptor expression during neuronal differentiation of murine embryonic stem cells. |
| Q34068717 | Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes |
| Q37680918 | SGK1-sensitive renal tubular glucose reabsorption in diabetes. |
| Q46392319 | Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome |
| Q35130314 | Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. |
| Q36238325 | The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology |
| Q35872736 | The protective side of the mineralocorticoid receptor |
Search more.